| Financial Year |
March 31 2023 |
| Monetary Funds |
207,531,069.72 |
| Held-for-trading Financial Assets |
225,961,551.31 |
| Notes Receivable |
126,081,350.64 |
| Accounts Receivable |
645,181,516.66 |
| Advances to Suppliers |
43,836,921.50 |
| Other Receivables |
5,168,781.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
433,518,479.54 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,652,320.21 |
| Total Current Assets |
1,890,339,154.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
262,005,643.66 |
| Investment Properties |
12,517,088.42 |
| Fixed Assetes |
589,292,058.76 |
| Under-construction Projects |
118,391,176.63 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
18,902,986.14 |
| R&D expenses |
-- |
| Goodwill |
227,231.14 |
| Long-Term Deferred and Prepaid Expenses |
1,203,398.01 |
| Deferred Income Tax Assets |
20,379,132.51 |
| Other Non-Current Assets |
11,768,465.00 |
| Sub-Total of Non-Current Assets |
1,493,919,508.08 |
| Total Assets |
3,384,258,662.97 |
| Short-Term Loans |
89,219,231.87 |
| Trading Financial liabilities |
10,648,980.00 |
| Notes Payable |
69,994,831.68 |
| Accounts Payable |
170,008,599.02 |
| Accounts Received In Advance |
3,648,799.39 |
| Employee Compensation Payable |
10,177,211.93 |
| Taxes Payable |
7,901,048.68 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
102,913,760.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,582,110.45 |
| Other Current Liabilities |
1,935,574.11 |
| Sub-Total of Current Liabilities |
487,493,824.18 |
| Long-term Loans |
59,493,281.13 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
26,374,615.60 |
| Other Non-Current Liabilities |
919,267.71 |
| Sub-Total of Non-Current Liabilities |
112,006,292.99 |
| Total Liabilities |
599,500,117.17 |
| Paid-In Capital(Or Share Stock) |
807,886,616.00 |
| Capital Surplus |
734,603,209.07 |
| Surplus Reserve |
152,318,678.40 |
| LESS:Treasury Stock |
45,151,052.26 |
| Undistributed Profits |
1,118,895,653.90 |
| Minority Stockholder's Interest |
23,990,549.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,760,767,996.69 |
| Owner's Equity（Stockholder's Equity） |
2,784,758,545.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,384,258,662.97 |
